Gene therapy for hemophilia

KP Ponder - Current opinion in hematology, 2006 - journals.lww.com
KP Ponder
Current opinion in hematology, 2006journals.lww.com
Gene therapy for hemophilia : Current Opinion in Hematology Gene therapy for hemophilia :
Current Opinion in Hematology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe
Register Login Articles & Issues Videos For Authors Journal Info Advanced Search September
2006 - Volume 13 - Issue 5 Previous Article Next Article Hemostasis and thrombosis Gene
therapy for hemophilia Ponder, Katherine P Author Information Departments of Internal …
Summary
Gene therapy has been successful in a patient with hemophilia B, but expression was unstable due to an immune response. Abrogating immune responses is the next major hurdle for achieving long-lasting gene therapy.
Lippincott Williams & Wilkins